The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers

Breast Cancer Research and Treatment
Irene CatucciPaolo Peterlongo

Abstract

The rs3834129 polymorphism, in the promoter of CASP8 gene, has been recently reported as associated with breast cancer risk in the general population, with the minor allele del having a protective effect. Some of the genetic variants found associated with breast cancer risk were reported as risk modifiers in individuals with mutations in BRCA1 and BRCA2 genes. Here, we tested the effect of the rs3834129 del allele on breast cancer risk in BRCA mutation carriers. The rs3834129 was genotyped in a total of 1,207 Italian female BRCA mutation carriers. Of these, 740 carried a BRCA1 mutation and 467 a BRCA2 mutation. Overall, 699 were affected with breast cancer and 508 were unaffected. When considering class 1 (loss-of-function) BRCA mutations, hazard ratios estimated by weighted multivariable Cox regression model, for individuals with at least one copy of the del allele, were 1.46 (95% confidence interval (CI): 1.08-1.99) for BRCA1 and BRCA2 mutation carriers combined, 1.74 (95% CI: 1.24-2.46) for BRCA1 mutation carriers, and 1.09 (95% CI: 0.66-1.80) for BRCA2 mutation carriers. These results suggest that the minor allele del of rs3834129 is associated under a dominant model with increased breast cancer risk in carriers of BRCA1 mu...Continue Reading

References

Sep 25, 2007·Breast Cancer Research and Treatment·Bernd FrankBarbara Burwinkel
Feb 29, 2008·Nature Genetics·Christopher A HaimanLoïc Le Marchand
Mar 13, 2008·Journal of the National Cancer Institute·Bernd FrankBarbara Burwinkel
Mar 18, 2008·Breast Cancer Research and Treatment·Giovanna De VecchiPaolo Peterlongo
Mar 22, 2008·American Journal of Human Genetics·Antonis C AntoniouUNKNOWN CIMBA
Jun 12, 2008·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·J PalaciosJ Benítez
Dec 3, 2008·Cancer Research·Dominika WokolorczykCezary Cybulski
Dec 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Montserrat Garcia-Closas, Stephen Chanock
Mar 26, 2009·Cancer Research·Neil Duncan ShephardAngela Cox
Jul 25, 2009·Breast Cancer Research and Treatment·Theodoros N Sergentanis, Konstantinos P Economopoulos
Aug 7, 2009·Human Molecular Genetics·Antonis C AntoniouUNKNOWN CIMBA

❮ Previous
Next ❯

Citations

Dec 12, 2012·BMC Medical Genetics·José Juvenal LinharesIsmael Dale Cotrim Guerreiro da Silva
Jul 22, 2015·Breast Cancer Research and Treatment·Boyoung ParkSue K Park
Jun 9, 2015·Hereditary Cancer in Clinical Practice·Cecilie HerambLovise Mæhle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.